Shots: Mylan to get exclusive commercialization rights of the product in >100 countries, including Africa, Asia, the Middle East, the Commonwealth of Independent States (CIS) and Latin America. Mylan plans to launch Mylan HIV Self-Test in global markets in 2019 CE-Marked in-vitro HIV rapid diagnostic tests allow individuals to detect presence or absence of HIV […]Read More
Tags : Low and Middle-Income Countries
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
EU
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US